Recombinant Mycobacterium vanbaalenii ATP synthase subunit b (atpF)

Basic Research Questions

• How is recombinant M. vanbaalenii ATP synthase subunit b (atpF) expressed and purified for research applications?

  According to available data, recombinant M. vanbaalenii ATP synthase subunit b (atpF) is typically expressed as a fusion protein with an N-terminal His-tag in Escherichia coli expression systems . The recommended expression and purification protocol includes:

  Step	Method	Details
  Expression system	E. coli	Using full-length protein (amino acids 1-166) with N-terminal His-tag
  Cell lysis	Sonication or pressure-based methods	In buffer containing protease inhibitors
  Initial purification	Immobilized metal affinity chromatography (IMAC)	Using Ni-NTA resin with increasing imidazole concentrations
  Secondary purification	Size exclusion chromatography	To remove aggregates and improve homogeneity
  Quality control	SDS-PAGE and Western blotting	To verify purity and identity
  Storage	Tris-based buffer with 50% glycerol	Store at -20°C, or -80°C for extended storage

  Repeated freezing and thawing should be avoided, and working aliquots can be stored at 4°C for up to one week .

• What is the significance of ATP synthase in mycobacterial energy metabolism and virulence?

  ATP synthase plays a critical role in mycobacterial bioenergetics and has several unique features that distinguish it from other bacterial homologs:

  The mycobacterial F1F0-ATP synthase complex is responsible for synthesizing ATP using the proton motive force (PMF) generated across the cytoplasmic membrane . Unlike many other bacteria, mycobacterial ATP synthase exhibits latent ATPase activity, which prevents wasteful ATP hydrolysis and alteration of the PMF that would be lethal to mycobacteria .

  Recent studies have identified ATP synthase as being induced during polycyclic aromatic hydrocarbon metabolism in M. vanbaalenii PYR-1, suggesting its involvement in adaptation to various growth conditions . This connection to metabolic versatility may contribute to the organism's survival in diverse environments.

  Furthermore, the essentiality of ATP synthase in mycobacterial species makes it an important drug target. The diarylquinoline bedaquiline, which specifically inhibits mycobacterial ATP synthase, is used to treat drug-resistant tuberculosis . Understanding the structure and function of all ATP synthase components, including subunit b, is crucial for developing new antimicrobial strategies.

• How do the structural features of mycobacterial ATP synthase differ from those of other bacterial species?

  Mycobacterial ATP synthase possesses several unique structural features that distinguish it from other bacterial ATP synthases:

  • Composition: The mycobacterial F1F0-ATP synthase has a subunit composition of α3:β3:γ:δ:ε:a:b:b′:c9 .

  • C-terminal extension: The nucleotide-binding subunit α contains a 3.5-kDa C-terminal extension (αCTD) that contributes significantly to the suppression of ATPase activity .

  • Latent ATPase activity: Mycobacterial F1F0-ATP synthases are incapable of ATP-driven proton translocation due to their latent ATPase activity, which prevents wasting of ATP and alteration of the proton motive force .

  • Additional structural elements: The mycobacterial ATP synthase contains an extra 14-amino-acid γ-loop and a specialized C-terminus of subunit ε that contribute to suppressing ATPase activity .

  These structural differences are functionally significant, as they confer unique regulatory properties to the mycobacterial ATP synthase and create opportunities for selective inhibition by antimicrobial compounds .

• What experimental applications are available for recombinant M. vanbaalenii ATP synthase subunit b (atpF)?

  Recombinant M. vanbaalenii ATP synthase subunit b (atpF) can be utilized in various experimental applications, including:

  • Structural studies: As a component for reconstituting ATP synthase complexes for X-ray crystallography or cryo-electron microscopy analyses .

  • Biochemical assays: In reconstitution experiments to study ATP synthesis and hydrolysis activities .

  • Protein-protein interaction studies: To investigate interactions with other ATP synthase subunits or potential regulatory proteins .

  • Antibody production: As an antigen for generating specific antibodies for detection and localization studies.

  • Drug screening: As part of reconstituted ATP synthase complexes to evaluate potential inhibitors .

  • Immunological research: For studying host immune responses to mycobacterial antigens, particularly in the context of vaccine development .

  These applications contribute to our understanding of ATP synthase function and can facilitate the development of new therapeutic strategies targeting mycobacterial energy metabolism.